Unraveling remyelination in multiple sclerosis From tissue heterogeneity to therapeutic target identification

Open Access
Authors
  • J.Q.A. Chen
Supervisors
Co-supervisors
Award date 24 November 2026
ISBN
  • 9789465378770
Number of pages 303
Organisations
  • Faculty of Science (FNWI) - Institute for Biodiversity and Ecosystem Dynamics (IBED)
  • Faculty of Science (FNWI)
Abstract
Multiple sclerosis (MS) is a chronic demyelinating and inflammatory disease of the central nervous for which no cure currently exists. Remyelination restores myelin around demyelinated axons, improves neurological function, and protects axons from degeneration. Understanding the mechanisms underlying efficient remyelination may support the development of regenerative therapies for MS. This thesis investigated molecular mechanisms associated with efficient remyelination, evaluated candidate therapeutic targets, and explored biomarkers of regenerative capacity.
In Part I, analyses of post-mortem MS brain tissue showed that poor remyelination was associated with a tissue environment characterized by foamy microglia, inflammation, increased immune cell activity, gliosis, and chronic scar formation, creating a less permissive milieu for oligodendrocyte differentiation and lesion repair. In Part II, candidate pro-remyelination molecules were evaluated in vitro, and ex vivo, and delivered to specific CNS cell types using AAV-mediated gene therapy in vivo. These studies highlighted the complexity of regenerative gene therapy and the importance of CNS cell-specific targeting and timing of intervention. In Part III, we identified candidate biomarkers for remyelination, which were elevated in efficient remyelinating patients from the ReBUILD clemastine trial and enriched in regenerative lesions in efficient remyelinating donors.
Overall, this thesis provides novel insights into successful and failed remyelination, and identifies candidate therapeutic targets and biomarkers for future clinical studies.
Document type PhD thesis
Language English
Downloads
Thesis (complete) (Embargo up to 24 November 2028)
Chapter 8: Soluble protein markers of remyelination in multiple sclerosis (Embargo up to 24 November 2028)
Permalink to this page
cover
Back